-+ 0.00%
-+ 0.00%
-+ 0.00%

Coastlands Capital reports acquisition of $805,944.1123 in Pasithea Therapeutics common shares

PUBT·11/18/2026 01:43:02
Listen to the news
Coastlands Capital reports acquisition of $805,944.1123 in Pasithea Therapeutics common shares
  • Coastlands Capital, a 10% owner, purchased 1,667,514 common shares of Pasithea Therapeutics, according to a beneficial ownership filing.
  • Indirect beneficial ownership rose to 5,502,549 common shares. Purchase prices were $0.4956, $0.4989 and $0.47 per share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pasithea Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-129251), on November 17, 2026, and is solely responsible for the information contained therein.